AMBS.US Amarantus Bioscience Holdings Inc

Healthcare Biotechnology USA Stocks
0.0001 USD
Close of Jul 3, 2026
Market cap
USD 63.0K
P/E
-
P/B
53.19x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2023.

Is AMBS.US undervalued?

Graham number

The Graham number of Amarantus Bioscience Holdings Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Amarantus Bioscience Holdings Inc fundamental analysis

No fundamental analysis for Amarantus Bioscience Holdings Inc yet.

Amarantus Bioscience Holdings Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Amarantus Bioscience Holdings Inc

Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company's diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer's disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple scleros…

Full company profile